Benlysta 200 MG/ML autoinjectml
Ended Awarded Last action
- Contract number
- SPE2DR26FR01F
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,497
Award facts
- Contract value 100% obligated
- $6,497.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,497.32 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injector units. This firm fixed-price delivery order, issued on December 5, 2025, with completion targeted for December 29, 2025, represents a non-competitive set-aside award. The product will be delivered to the performance location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a child contract under a larger vehicle, this delivery order leverages AmerisourceBergen's established pharmaceutical distribution capabilities to support federal medical procurement needs.
This award is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999 global pharmaceutical support vehicle extending through December 2026. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, supplies a broad spectrum of pharmaceuticals, specialty medications, vaccines, and medical devices to support military and veteran healthcare systems. Benlysta, a biologic medication used to treat systemic lupus erythematosus, represents one of the specialized pharmaceutical products the company delivers through its DLA framework agreement, demonstrating its role as a critical vendor for federal medical supply chain operations serving the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FR01F?
SPE2DR26FR01F was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 5, 2025.
How much is contract SPE2DR26FR01F worth?
The government has obligated $6,497 on SPE2DR26FR01F.
Is contract SPE2DR26FR01F an order under another contract?
Yes. SPE2DR26FR01F is a delivery order under SPE2DR25D2003, an indefinite delivery contract.
Was contract SPE2DR26FR01F competed?
The extent of competition for SPE2DR26FR01F was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award